Reference no: EM131752476 
                                                                               
                                       
Question: Analyzing and Assessing Research and Development Expenses
Advanced Micro Devices (AMD) and Intel (INTC) are competitors in the computer processor industry. Following is a table ($ millions) of sales and R&D expenses for both companies.
 
| AMD 
 | R&D Expense | Sales | 
 
| 2012 | $ 1,354 | $ 5,422 | 
| 2011 | 1,453 | 6,598 | 
| 2010 | 1,405 | 6,494 | 
 
| INTC | R&D Expense | Sales | 
 
| 2012 | $ 10,148 | $ 53,341 | 
| 2011 | 8,530 | 53,999 | 
| 2010 | 6,576 | 43,623 | 
(a) What percentage of sales are AMD and INTC spending on research and development? (Round your answers to one decimal place.)
 
| 
 | AMD | INTC | 
 
| 2012 | Answer% | Answer% | 
| 2011 | Answer% | Answer% | 
| 2010 | Answer% | Answer% | 
(b) Which of the following statements best describes how AMD's and INTC's balance sheets and income statements are affected by accounting for R&D costs?
- R&D assets increase the balance sheets of both companies.
- Accounting for R&D costs increases profitability because the expensing of R&D costs is deferred and revenues from R&D-related projects are recognized in current income.
- R&D is initially recognized on the balance sheet and, subsequently, amortized (similar to depreciation of PPE).
- Expensing R&D costs (rather than capitalizing and depreciating them) results in unrecorded assets on both AMD's and INTC's balance sheets.
(c) Which of the following statements best explains how we evaluate R&D spending for effectiveness and/or involvement (via R&D as a percent of sales)?
- We can infer the sole effectiveness of R&D by measuring R&D expense as a percentage of sales.
- Over time, the number and quality of new product introductions, number of patents, and related measures, can be compared across companies and against relative levels of R&D spending.
- Because R&D costs are capitalized on the balance sheet, we can gauge the effectiveness of R&D spending by looking at the amount of R&D assets that are recognized.
- R&D costs typically remain constant in absolute dollars, but decline each year as a percentage of sales when revenues increase.